Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $21.66 and traded as high as $24.61. Palatin Technologies shares last traded at $24.61, with a volume of 14 shares.
Palatin Technologies Stock Up 0.2%
The company has a market cap of $986,400.00, a PE ratio of -15.91 and a beta of -1.47. The business has a 50-day simple moving average of $24.53 and a 200-day simple moving average of $21.78.
Palatin Technologies Company Profile
Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating appetite, sexual function, inflammation, and other physiological processes. The company’s research programs are intended to address conditions in areas such as obesity, sexual dysfunction, inflammatory disease, and related disorders.
Palatin’s best-known product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S.
Further Reading
- Five stocks we like better than Palatin Technologies
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
